These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
839 related items for PubMed ID: 7808028
1. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan. Ohno R, Ohnishi K, Takeshita A, Tanimoto M, Murakami H, Kanamaru A, Asou N, Kobayashi T, Kuriyama K, Ohmoto E. Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028 [Abstract] [Full Text] [Related]
2. Multi-institutional study of all-trans-retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia. Leukaemia Study Group of the Ministry of Health and Welfare. Ohno R, Yoshida H, Fukutani H, Naoe T, Ohshima T, Kyo T, Endoh N, Fujimoto T, Kobayashi T, Hiraoka A. Leukemia; 1993 Nov; 7(11):1722-7. PubMed ID: 8231241 [Abstract] [Full Text] [Related]
3. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience]. Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N. Srp Arh Celok Lek; 1995 Nov; 123(11-12):279-85. PubMed ID: 16296239 [Abstract] [Full Text] [Related]
5. [Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid]. Ohno R. Gan To Kagaku Ryoho; 1993 Feb; 20(2):189-93. PubMed ID: 8434955 [Abstract] [Full Text] [Related]
6. [Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid]. Ohno R, Naoe T, Fukutani H. Gan To Kagaku Ryoho; 1993 Jun; 20(8):1016-21. PubMed ID: 8390226 [Abstract] [Full Text] [Related]
7. Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG). Asou N, Adachi K, Tamura U, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama U, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake H, Ohno R. Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S65-71. PubMed ID: 11587370 [Abstract] [Full Text] [Related]
8. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. Asou N, Adachi K, Tamura J, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama K, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake S, Suzushima H, Emi N, Ohno R. J Clin Oncol; 1998 Jan; 16(1):78-85. PubMed ID: 9440726 [Abstract] [Full Text] [Related]
9. Management of acute promyelocytic leukemia relapse in the ATRA era. Castagnola C, Lunghi M, Corso A, Tajana M, Zappasodi P, Dabusti M, Lazzarino M, Bernasconi C. Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255 [Abstract] [Full Text] [Related]
10. All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG). Asou N, Adachi K, Tamura J, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Sakamaki H, Tsubaki K, Saito K, Ohno R. Cancer Chemother Pharmacol; 1997 Aug; 40 Suppl():S30-5. PubMed ID: 9272131 [Abstract] [Full Text] [Related]
11. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group. Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K. Blood; 1995 Mar 01; 85(5):1202-6. PubMed ID: 7858250 [Abstract] [Full Text] [Related]
12. Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience. Cheng Y, Zhang L, Wu J, Lu A, Wang B, Liu G. Eur J Haematol; 2013 Dec 01; 91(6):483-9. PubMed ID: 24033687 [Abstract] [Full Text] [Related]
13. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL). Gupta V, Yi QL, Brandwein J, Lipton JH, Messner HA, Schuh AC, Wells RA, Minden MD. Leuk Res; 2005 Jan 01; 29(1):113-4. PubMed ID: 15541484 [Abstract] [Full Text] [Related]
15. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. de Botton S, Coiteux V, Chevret S, Rayon C, Vilmer E, Sanz M, de La Serna J, Philippe N, Baruchel A, Leverger G, Robert A, San Miguel J, Conde E, Sotto JJ, Bordessoule D, Fegueux N, Fey M, Parry A, Chomienne C, Degos L, Fenaux P. J Clin Oncol; 2004 Apr 15; 22(8):1404-12. PubMed ID: 15084614 [Abstract] [Full Text] [Related]